Back
Rocket Pharmaceuticals Vs. Ligand Pharmaceuticals Industry Stock Comparison
Buy
60
RCKT
Rocket Pharmaceuticals
Last Price:
23.41
Seasonality Move:
17.22%
Buy
68
LGND
Ligand Pharmaceuticals
Last Price:
84.84
Seasonality Move:
0.89%
Buy
60
Rocket Pharmaceuticals (RCKT)
is a Buy
Is Rocket Pharmaceuticals a Buy, Sell or Hold?
- The current Rocket Pharmaceuticals [RCKT] share price is $23.66. The Score for RCKT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- RCKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
68
Ligand Pharmaceuticals (LGND)
is a Buy
Is Ligand Pharmaceuticals a Buy, Sell or Hold?
- The current Ligand Pharmaceuticals [LGND] share price is $85.77. The Score for LGND is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- LGND is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RCKT Stock Price Chart
What is Rocket Pharmaceuticals's stock price today?
-
The Rocket Pharmaceuticals share price today is $23.66
The current trend is relatively stagnant and RCKT is experiencing selling pressure, which indicates risk of future bearish movement.
LGND Stock Price Chart
What is Ligand Pharmaceuticals's stock price today?
-
The Ligand Pharmaceuticals share price today is $85.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LGND is experiencing slight buying pressure.
RCKT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.44 | Sell |
Relative Strength Index (14 RSI): | 49.95 | Sell |
Chaikin Money Flow: | -301284 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.41 - 24.05) | Buy |
Bollinger Bands (100): | (24.4 - 29.56) | Sell |
LGND Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.83 | Buy |
Relative Strength Index (14 RSI): | 67.49 | Buy |
Chaikin Money Flow: | 5257 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (70.36 - 82.46) | Buy |
Bollinger Bands (100): | (70.3 - 78.88) | Buy |
RCKT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 23.22 | Buy |
20-day SMA: | 22.97 | Buy |
50-day SMA: | 24.94 | Sell |
200-day SMA: | 23.37 | Buy |
8-day EMA: | 23.22 | Buy |
20-day EMA: | 23.38 | Buy |
50-day EMA: | 24.59 | Sell |
200-day EMA: | 24.04 | Sell |
LGND Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 81.89 | Buy |
20-day SMA: | 75.44 | Buy |
50-day SMA: | 75.06 | Buy |
200-day SMA: | 67.6 | Buy |
8-day EMA: | 82.37 | Buy |
20-day EMA: | 78.49 | Buy |
50-day EMA: | 75.99 | Buy |
200-day EMA: | 71.74 | Buy |
Rocket Pharmaceuticals Earnings Growth & RCKT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.18 per share, an increase this year of $0.37 per share, and an increase next year of $0.63 per share.
Ligand Pharmaceuticals Earnings Growth & LGND Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.07 per share, a decrease this year of $0.71 per share, and an increase next year of $0.91 per share.
Rocket Pharmaceuticals Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Ligand Pharmaceuticals Technical Analysis
May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
02 | 03 | 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |